<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35136">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01888120</url>
  </required_header>
  <id_info>
    <org_study_id>13-001</org_study_id>
    <nct_id>NCT01888120</nct_id>
  </id_info>
  <brief_title>Patient Registry of Intrathecal Ziconotide Management(PRIZM)</brief_title>
  <acronym>PRIZM</acronym>
  <official_title>Patient Registry of Intrathecal Ziconotide Management (PRIZM): An Open-Label, Long Term, Multi-Center, Observational Study of PRIALT® (Ziconotide) Solution, Intrathecal Infusion, in Patients With Severe Chronic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jazz Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jazz Pharmaceuticals</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to evaluate the effectiveness, long-term safety,
      tolerability, satisfaction with treatment, and health-related quality of life (HRQoL)
      associated with Intrathecal PRIALT use for severe chronic pain of varying etiologies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>18 Months</target_duration>
  <primary_outcome>
    <measure>The effectiveness of PRIALT therapy for the management of severe chronic pain as evidenced by change in patient-reported pain intensity from baseline to 12 weeks after enrollment</measure>
    <time_frame>12 Weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the following from the patient's perspective via patient reported outcomes (PROs)</measure>
    <time_frame>From week 12, every 3 months up to month 18</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the patient's global impression of change (PGIC) with PRIALT treatment</measure>
    <time_frame>From week 12, every 3 months up to month 18</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate changes in concomitant pain medication use</measure>
    <time_frame>From week 12, every 3 months up to month 18</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate long-term safety and tolerability data, including incidence and severity of adverse events (AEs) and serious adverse events (SAEs)</measure>
    <time_frame>From week 12, every 3 months up to month 18</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The use of PRIALT in current clinical practice including dose at initiation, titration speed, effective dose, duration of treatment effect, use of other pain medications, etc.</measure>
    <time_frame>From week 12, every 3 months up to month 18</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Patients With Severe Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Severe Chronic Pain</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ziconotide</intervention_name>
    <arm_group_label>Severe Chronic Pain</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Up to 140 patients will be enrolled at approximatley 50 sites in the United States.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is at least 18 years of age at the time of study entry.

          -  Patient who has severe chronic pain, whom IT therapy is warranted, and who is
             intolerant of, or refractory to other treatments, such as systemic analgesics,
             adjunctive therapies, and/or IT morphine.

          -  Patient is planned to be initiated on IT PRIALT as the sole agent in the pump at a
             participated site.

          -  Patient has not received PRIALT treatment administered continuously via Medtronic
             SynchroMed® II pump within the past 30 days.

          -  Patient has a life expectancy &gt;6 months as determined by the physician.

          -  Patient is able to read, understand, and voluntarily sign the IRB-approved informed
             consent document prior to the performance of any study-specific procedures.

          -  Patient is able to understand and complete required assessments.

        Exclusion Criteria:

          -  Patient has a known hypersensitivity to PRIALT or any of its formulation components.

          -  Patient has a pre-existing history of psychosis.

          -  Patient has infection at the microinjection site, uncontrolled bleeding diathesis, or
             known spinal canal obstruction that impairs circulation of cerebrospinal fluid.

          -  Patient is being initiated with PRIALT in conjunction with other IT agents.

          -  Patients with any other concomitant treatment or medical condition that, in the
             opinion of the clinician, would render IT administration hazardous.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tennessee Valley Pain Consultants</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marsha Arnold</last_name>
      <phone>256-265-7248</phone>
    </contact>
    <investigator>
      <last_name>Ronald Collins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Valley pain Consultants</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <zip>85224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jo Molinaro</last_name>
      <phone>602-320-1050</phone>
    </contact>
    <investigator>
      <last_name>Joseph Curletta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>White River Medical Center Pain Management Clinic</name>
      <address>
        <city>Batesville</city>
        <state>Arkansas</state>
        <zip>72501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Mowery</last_name>
      <phone>413-230-4598</phone>
    </contact>
    <investigator>
      <last_name>Meraz Siddiqui, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>United Pain Care</name>
      <address>
        <city>Sherwood</city>
        <state>Arkansas</state>
        <zip>72120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahmood Ahmad, MD</last_name>
      <phone>501-626-7589</phone>
    </contact>
    <investigator>
      <last_name>Mahmood Ahmad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurovations</name>
      <address>
        <city>Napa</city>
        <state>California</state>
        <zip>94558</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renee Bell</last_name>
      <phone>707-252-9606</phone>
    </contact>
    <investigator>
      <last_name>Eric Grigsby, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cypress Ambulatory Surgery Center</name>
      <address>
        <city>Santa Maria</city>
        <state>California</state>
        <zip>93454</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neona Lotz</last_name>
      <phone>805-361-5088</phone>
    </contact>
    <investigator>
      <last_name>Timothy Kuang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Colorado Pain Clinic</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <zip>80538</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaclyn Summers</last_name>
      <phone>970-221-9451</phone>
    </contact>
    <investigator>
      <last_name>Brad Sisson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Interventional Pain &amp; Spine</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Blackshaw</last_name>
      <phone>302-266-7800</phone>
    </contact>
    <investigator>
      <last_name>Philip Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clearwater Pain Management Associates</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Demetrios Kaiafas, MD</last_name>
      <phone>727-743-4687</phone>
    </contact>
    <investigator>
      <last_name>Demetrios Kaiafas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Pain</name>
      <address>
        <city>Merritt Island</city>
        <state>Florida</state>
        <zip>32953</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Gayles, MD</last_name>
      <phone>321-784-8211</phone>
    </contact>
    <investigator>
      <last_name>Richard Gayles, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AMPM Research Clinic</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33169</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Drouillard</last_name>
      <phone>305-646-6955</phone>
    </contact>
    <investigator>
      <last_name>Abel Murillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kennedy-White Orthopaedic Center</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Levine</last_name>
      <phone>941-552-7875</phone>
    </contact>
    <investigator>
      <last_name>Donald Erb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pain Management, PM&amp;R</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ismari Clesson</last_name>
      <phone>404-350-7651</phone>
    </contact>
    <investigator>
      <last_name>Erik Shaw, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spine &amp; Skeletal Pain Medicine</name>
      <address>
        <city>Utica</city>
        <state>New York</state>
        <zip>13502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Dermady</last_name>
      <phone>315-798-8737</phone>
    </contact>
    <investigator>
      <last_name>Nameer Haider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Center for Clinical Research</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jill Brewer</last_name>
      <phone>336-765-6181</phone>
    </contact>
    <investigator>
      <last_name>Richard Rauck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Integrated Pain Solutions</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristy Whitlock</last_name>
      <phone>614-383-6453</phone>
    </contact>
    <investigator>
      <last_name>Gladstone McDowell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ashland Neurosurgery</name>
      <address>
        <city>Ashland</city>
        <state>Oregon</state>
        <zip>97520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandon Atha</last_name>
      <phone>541-488-4888</phone>
    </contact>
    <investigator>
      <last_name>Luc Jasmin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Anesthesiologist Group</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stuart Rosenblum</last_name>
      <phone>503-517-3785</phone>
    </contact>
    <investigator>
      <last_name>Stuart Rosenblum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DNA Health Systems</name>
      <address>
        <city>Greensburg</city>
        <state>Pennsylvania</state>
        <zip>15601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krisit Steele</last_name>
      <phone>412-489-4681</phone>
    </contact>
    <investigator>
      <last_name>Brinda Navalgund, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Pain Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erica Butler</last_name>
      <phone>832-553-1336</phone>
    </contact>
    <investigator>
      <last_name>Allen Burton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Center for Pain Relief</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy Deer, MD</last_name>
      <phone>304-347-6120</phone>
    </contact>
    <investigator>
      <last_name>Timothy Deer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Ukraine</country>
  </removed_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 19, 2014</lastchanged_date>
  <firstreceived_date>June 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ziconotide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
